Novo Nordisk Receives FDA Approval for Xultophy® 100/3.6 (insulin degludec and liraglutide injection)
Novo Nordisk - Looking for ways to save on your #diabetes medication? Visit our patient support program, NovoCare®, to see how our savings and support tools can help.👉 www.novocare.com | Facebook
![Novo's diabetes medication Victoza keeps growing, despite Lilly's market-share creep | Fierce Pharma Novo's diabetes medication Victoza keeps growing, despite Lilly's market-share creep | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/2016-10/novonordisk.jpg?VersionId=W_GvWnm7A8Yf23wJABNrI6jSrkkO04Mf)